Subscriber access provided by CORNELL UNIVERSITY LIBRARY
Article
Bacteriophages as factories for Eu2O3 nanoparticle synthesis Piotr Golec, Kamila #elechowska, Joanna Karczewska-Golec, Jakub Karczewski, Adam Lesniewski, Marcin #o#, Grzegorz Wegrzyn, and Andrzej M. Klonkowski Bioconjugate Chem., Just Accepted Manuscript • Publication Date (Web): 08 May 2017 Downloaded from http://pubs.acs.org on May 10, 2017
Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a free service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are accessible to all readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.
Bioconjugate Chemistry is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.
Page 1 of 26
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Bioconjugate Chemistry
1
Bacteriophages as factories for Eu2O3 nanoparticle synthesis
2
Running title: Eu2O3 NPs synthesis by modified M13 phage
3
4
Piotr Goleca*, Kamila Żelechowskab, Joanna Karczewska-Golecc,d, Jakub Karczewskib, Adam
5
Leśniewskie, Marcin Łośd, Grzegorz Węgrzync, Andrzej M. Kłonkowskif
6
a
7
Biochemistry and Biophysics, Polish Academy of Sciences, Wita Stwosza 59, 80-308 Gdansk, Poland
8
b
9
Technology, Narutowicza 11/12, 80-233 Gdansk, Poland
Laboratory of Molecular Biology (affiliated with the University of Gdansk), Institute of
Faculty of Applied Physics and Mathematics, Solid State Physics Department, Gdansk University of
10
c
Department of Molecular Biology, University of Gdansk, Wita Stwosza 59, 80-308 Gdansk, Poland
11
d
Department of Bacterial Molecular Genetics, University of Gdansk, Wita Stwosza 59, 80-308
12
Gdansk, Poland
13
e
14
Poland
15
f
Institute of Physical Chemistry, Polish Academy of Sciences, Kasprzaka 44/52, 01-224 Warsaw,
Faculty of Chemistry, University of Gdansk, Wita Stwosza 63, 80-308 Gdansk, Poland
16
17
* Corresponding author: Dr. Piotr Golec, Laboratory of Molecular Biology (affiliated with the
18
University of Gdansk), Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Wita
19
Stwosza 59, 80-308 Gdansk, Poland, Tel.: +48 58 523 6041, Fax: +48 58 523 6025, e-mail:
20
[email protected] 21
KEYWORDS: europium oxide, europium oxide nanoparticles, luminescent materials, phage
22
display 1 ACS Paragon Plus Environment
Bioconjugate Chemistry
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 2 of 26
23
ABSTRACT
24
The use of phage display to identify peptides with an ability to bind Eu2O3 is demonstrated in
25
this report. This is the first report of modified phages specifically binding a lanthanide. The
26
peptides exposed on virions revealed very strong binding to Eu2O3 nanoparticles and the
27
ability to catalyze Eu2O3 nanoparticles’ formation from Eu(OH)3 and Eu(NO3)3 solutions. The
28
luminescence emission spectrum of Eu3+ ions indicated that these ions existed mostly in sites
29
deviated from the inversion symmetry in crystalline Eu2O3 aggregates and gelatinous
30
Eu(OH)3 precipitate. The ability of phage-displayed peptides to catalyze formation of Eu2O3
31
nanoparticles provides a useful tool for a low-cost and effective synthesis of lanthanide
32
nanoparticles, which serve as attractive biomedical sensors or fluorescent labels, among their
33
other applications.
34
35
INTRODUCTION
36
There are many potential applications of Eu3+, ranging from color displays to
37
biomedical sensors1-4. Light emission from Eu3+ ions varies depending on the site symmetry
38
and is associated with 5D0 → 7FJ (J = 0 - 4) transitions5. Under basic conditions, Eu3+ ions
39
commonly form europium hydroxide, which can be converted to europium oxide by high-
40
temperature annealing. As a matter of fact, Eu2O3 is considered to be one of the best oxide
41
phosphors, thus the interest in this material is undoubtedly justified. Interestingly, Eu2O3
42
nanostructures have a higher packing density and a larger percentage of active sites than the
43
bulk material6.
44
Nanocrystalline Eu2O3 can be synthesized in a number of processes, including sol-gel
45
techniques7, laser evaporation8, gas-phase condensation9, colloidal chemical method10, and
46
sonochemical techniques11. Ultrathin nanodisks as well as one-dimensional (1D) Eu2O3 2 ACS Paragon Plus Environment
Page 3 of 26
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Bioconjugate Chemistry
47
nanostructures, including nanotubes, nanorods and nanowires, have particularly interesting
48
optical properties12. While Eu2O3 nanorods were synthesized by thermal conversion (700°C)
49
of amorphous Eu(OH)3 nanorods prepared by ultrasonication13, Eu2O3 nanotubes and
50
nanorods were prepared by a hydrothermal method14, 15. More recently, Eu2O3 nanorods have
51
also been synthesized by a precipitation method16 and by a sol-gel template approach17.
52
Similarly, Eu2O3 spindles of different aspect ratio were prepared via a polyethylene glycol-
53
assisted reflux method18 and later by a room temperature (RT) precipitation method19.
54
Aside from the rare metals 1D-type structures, the hollow sphere nanostructures have
55
also attracted much attention and their potential applications in therapy, energy storage and
56
catalysis were proposed. For example, Li et al.20 obtained mesoporous Eu2O3 microspheres by
57
calcining an europium precursor synthesized hydrothermally. A similar two-step methodology
58
leading to europium oxide spheres was later reported21. In the first step, sphere precursors
59
were prepared in the hydrothermal reaction of EuCl3·6H2O and 6-aminonicotinic acid. Then,
60
a heat treatment of precursors under inert atmosphere yielded the final material, which
61
exhibited a spherical morphology and a well-defined mesoporous structure. Similarly,
62
europium oxide hollow spheres were synthesized in the improved sol-gel method using
63
polymeric microspheres as templates.
64
Besides the physicochemical approaches to the production of europium oxide
65
nanoparticles (NP) or Eu2O3 NPs-based materials, biological techniques such as phage display
66
could potentially be useful, however, such a possibility has not been explored for lanthanide
67
ions so far. Phage display, developed in 1985 by George P. Smith22, uses bacteriophages
68
(viruses that infect bacteria) as carriers to display short peptides. The most common phage in
69
this technique is M13, which is easy to manipulate genetically. A DNA sequence encoding
70
the peptide of interest may be inserted into M13 genes coding for phage coat proteins, e.g.
71
pIII or pVIII23. As a result, the protein of interest, which has usually seven or 12 amino acids, 3 ACS Paragon Plus Environment
Bioconjugate Chemistry
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
72
is presented outside of the phage virion and is able to bind biological molecules (DNA
73
sequences, peptides or proteins), nanoparticles, or other materials24-27. With the use of a huge
74
phage display peptide library (i.e. a great number of phages that present various peptide
75
sequences), it is possible to identify a specific peptide capable of binding the materials or
76
molecules of interest. Although peptides with high affinity for diverse inorganic materials,
77
including metals (e.g. gold, silver or chromium), metal and semi-metal oxides (e.g. silicon,
78
germanium, titanium or zinc oxides) and metal sulfides (e.g. ZnS, CdS), were reported28, the
79
sequence of europium oxide binding peptide was not - to the best of our knowledge -
80
previously identified.
81
Page 4 of 26
In this paper, the Eu2O3 binding peptide is reported for the first time and a new method
82
for formation of Eu2O3 nanoparticles is described. We proved that the isolated peptide is able
83
to mineralize europium oxide in the form of nanoparticles from the europium salt solution
84
(europium nitrate) as well as from the Eu(OH)3 solution. It should be underlined that only
85
phages presenting the peptide sequence and the Eu2O3 precursor, and no thermal treatment,
86
were required for the synthesis of Eu2O3 quantum dots that exhibited light emission
87
properties.
88
89
RESULTS AND DISCUSSION
90
Isolation of Eu2O3-binding peptides
91
For isolation of phages that expose Eu2O3 binding peptides, we employed the
92
commercially available Phage Display Peptide Library (NEB), in which a random peptide
93
(12-mer) is expressed at the N-terminus of minor coat protein (pIII) of M13 phage. The phage
94
display library used consists of approximately 1011 various amino acid sequences (each of
95
them in approximately 100 copies) in one ml of the library and had successfully been 4 ACS Paragon Plus Environment
Page 5 of 26
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Bioconjugate Chemistry
96
employed previously in numerous applications, including epitope mapping29, and the
97
identification of: anti-microbial/anti-viral peptides30, material-specific peptides31, small
98
molecule binders26 and novel enzyme substrates32. After three rounds of biopanning
99
procedure, which was carried out with the efficiency of around 10%, 20 phages were
100
randomly chosen for sequencing. Eighteen phage clones contained a foreign peptide insertion
101
within the pIII protein. The identified peptide sequences are presented in Tab. 1. The
102
sequencing analysis revealed the same peptide sequence (SRTGNWTRIDQS) in phages: M13
103
PG-Eu-1, M13 PG-Eu-3 and M13 PG-Eu-12. A very similar sequence (SRTGIWTRTDRS)
104
was observed in phage M13 PG-Eu-4.
105
106
Table 1. Amino acid sequences of the identified Eu2O3-binding peptides exposed on pIII
107
protein of M13 phage after three rounds of a biopanning procedure. a Isoelectric points (pI)
108
were calculated using pI/molecular weight tool available at http://ca.expasy.org Clone No. M13 PG-Eu-1 M13 PG-Eu-2 M13 PG-Eu-3 M13 PG-Eu-4 M13 PG-Eu-5 M13 PG-Eu-6 M13 PG-Eu-7 M13 PG-Eu-8 M13 PG-Eu-9 M13 PG-Eu-10 M13 PG-Eu-11 M13 PG-Eu-12 M13 PG-Eu-13 M13 PG-Eu-14 M13 PG-Eu-15 M13 PG-Eu-16 M13 PG-Eu-17 M13 PG-Eu-18
Sequence S R T A R Y S R T S R T D G Q N S V K A S I N P W D P Y A G N T L S R T R L I Y R A W N G G S S H T R F A T
G F G G S H F Y W E L G D G P S Q S
N A N I D R Y A S P L N K Q K K W R
W R W W L A N Q R V N W K V L G S L
T H T T S A V H V S M T P V V S G I
R P R R P L T P M V D R D M S A S D
I T I T R G S T G P P I A N N F G T
D A D D P P L G P G S D F V G V Q L
Q M Q R P G N S N T V Q I G D T M A
S G S S H T E I T S V S T A G A F S
pIa 9.31 10.84 9.31 11.70 5.21 9.76 6.00 6.74 5.84 4.00 3.80 9.31 8.59 8.75 5.84 8.75 9.76 5.84
109
110 5 ACS Paragon Plus Environment
Bioconjugate Chemistry
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
111
112
Page 6 of 26
The binding efficiency of the selected peptide to Eu2O3 The first 10 phages from Tab. 1 exposing various peptide sequences with a wide range
113
of isoelectric points (4.0 to 11.70) were chosen for further analyses. To evaluate the Eu2O3
114
binding efficiency (presented in Fig. 1), we calculated the output/input (O/I) ratio, as
115
described in the Experimental Procedures section. The highest O/I ratio was achieved in the
116
case of M13 PG-Eu-3 and M13 PG-Eu-1 phages, which expose the same peptide sequence
117
(SRTGNWTRIDQS). Binding efficiency of this peptide to Eu2O3 was around 0.1, which is
118
two or more orders of magnitude higher than the O/I ratio reported previously for binding
119
other small molecules, like titanium33 or ZnO26. This result suggests that the sequence reveals
120
a strong ability to bind Eu2O3 NPs under the tested conditions. Additionally, it is easy to see
121
that all examined sequences have a significantly higher ability to bind Eu2O3 NPs in
122
comparison to the control M13Ke phage. The identified sequences have various pI, and may
123
potentially bind Eu2O3 NPs with higher efficiency under different conditions than those used
124
in this study.
125
an attractive labeling agent to be used in immunoassays. Nanoparticles of Eu2O3 and Eu3+
126
were previously employed as fluorescent labels of atrazine, a selective triazine herbicide and
127
one of the most commonly detected pesticides in the US waters34, and of human prostate-
128
specific antigen (PSA), respectively35.
With such a substantial ability to bind Eu2O3 NPs, the identified peptides are
129 130
131
132
133
6 ACS Paragon Plus Environment
Page 7 of 26
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Bioconjugate Chemistry
134 135
Figure 1. Efficiency of Eu2O3 binding by peptides (listed in rows 1 to 10 in Tab. 1) exposed
136
on pIII protein on phage virions. The efficiency was estimated as O/I (Output/Input) ratio.
137
The patterned bars present efficiency of Eu2O3 binding by the same peptide sequence
138
(SRTGNWTRIDQS). In control experiments, the unmodified M13KE phage was used. The
139
presented results are average values from three experiments with SD represented by error
140
bars.
141
142
The high efficiency and the specificity of binding Eu2O3 nanoparticles by M13 PG-Eu-
143
3 was further confirmed with the use of atomic force microscopic (AFM) imaging (Fig. 2).
144
Figure 2a reveals the large number of M13 PG-Eu-3 phages on Eu2O3 modified mica surface.
145
It is easy to see that M13 PG-Eu-3 phages are put in order such that they bind to Eu2O3 NPs
146
with one end of the virion, where the SRTGNWTRIDQS peptide is presented. In a control
147
experiment, when M13 PG-Eu-3 phages were replaced with M13KE, there were only few
148
cases of interactions between phages and the modified mica (Fig. 2b).
149
7 ACS Paragon Plus Environment
Bioconjugate Chemistry
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
a
Page 8 of 26
b
150 151
Figure 2. AFM images (5 x 5 µm) of phage M13 PG-Eu-3 (a) and M13KE (CTRL) (b)
152
interacting with mica modified with Eu2O3 nanoparticles. The white spots represent Eu2O3
153
NPs, and the filamentous structures are M13 bacteriophages.
154
155
Eu2O3 nanoparticles synthesis
156
The ability of M13 PG-Eu-3 to synthesize nanostructures was explored using two
157
different Eu(III) precursors, i.e. europium nitrate solution and europium hydroxide solution.
158
First, europium nitrate was analyzed. Scanning electron microscope (SEM) images of dried
159
samples are shown in Fig. 3a-c. The nanoparticles sized below 10 nm were synthesized only
160
in the presence of M13 PG-Eu-3 and can clearly be seen in Fig. 3b, along with virions present
161
in the analyzed sample. In the case of control experiments with phage M13KE, no
162
nanoparticles were detected and phages were covered with an amorphous layer of salt (Fig
163
3c). Energy-dispersive X-ray (EDX) spectroscopic analysis indicated that the structures of
164
about 1 µm, that can be spotted in the Fig. 3a and 3c, were composed mainly of sodium and
165
chlorine, which were TBS buffer components.
166
8 ACS Paragon Plus Environment
Page 9 of 26
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Bioconjugate Chemistry
167 168
Figure 3. SEM images of Eu2O3 NPs synthesized by phages used as bio-templates. M13 PG-
169
Eu-3 phages and Eu2O3 nanoparticles are shown in panels (a) and (b), while no nanoparticles
170
could be observed in the control experiment with phage M13KE (c). Nanostructures
171
synthesized by M13 PG-Eu-3 phages and forming cauliflower-like structures are shown in
172
panel (d), and single nanoparticles located at the virion tips are visible in panel (e). The
173
structures marked as 1 and 2 in the picture (d) were analyzed by EDX spectroscopy. Panel (e)
174
shows SEM image of nanoparticles synthesized by M13 PG-Eu-3, after centrifugation. Scale
175
bars represent 1 µm.
176 9 ACS Paragon Plus Environment
Bioconjugate Chemistry
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 10 of 26
177
In the next step, the ability of M13 PG-Eu-3 phages to mineralize europium oxide
178
from europium hydroxide solution was verified. Since in the control experiment described
179
above we had observed the formation of salt crystals, in this experiment phages suspended in
180
distilled water were used. Dried samples were analyzed by SEM with EDX, in order to
181
determine the NPs morphology and elemental composition. Results are shown in Fig. 3d and
182
3e and listed in Table 2. In the synthesis with M13 PG-Eu-3 phages as biotemplates,
183
spectacular cauliflower-like nanostructures were formed. Further magnification of the
184
structures (see inset in Fig. 3d) revealed, that they are composed of very small (less than 5
185
nm) nanoparticles. Phages can be seen as bundles of fibrous structures. Along with the
186
cauliflower-like structures, the formation of single, small nanoparticles, placed near virion
187
tips, was detected (Fig. 3e). This diversity may be explained by inhomogeneous phage
188
dispersion and by the differences in precursor diffusion in the reaction mixture, leading to the
189
different distribution of NPs in the analyzed sample. Not surprisingly, NPs were located near
190
phage tips, as the Eu2O3-binding peptide is exposed on pIII protein of M13 placed on one of
191
the virion ends. The elemental composition of the sample with atomic and weight percentage
192
is listed in Table 2. The point EDX analysis confirmed the presence of europium in the
193
cauliflower-like structure (spot 1 in Fig. 3d) and the absence of europium on the phage capsid
194
surface (spot 2 in Fig. 3d), giving an indirect evidence of Eu2O3 mineralizing ability of M13
195
PG-Eu-3.
196
197
198
199
10 ACS Paragon Plus Environment
Page 11 of 26
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Bioconjugate Chemistry
200
Table 2. Elemental composition of the Eu2O3 nanomaterial obtained. Analysis was carried out
201
for the spots 1 and 2 depicted in Fig. 3d.
202 Element
CK
Na K
Cl K
KK
Eu L
Weight [%]
203
204
OK
Spot 1
29.95
29.79
28.97
6.54
0.72
4.03
Spot 2
57.06
23.38
14.6
3.55
1.4
–
Atomic [%] Spot 1
42.65
31.86
21.56
3.15
0.32
0.45
Spot 2
68.03
20.93
9.1
1.43
0.51
–
205
206
207
Since in the SEM images (Fig. 3d and 3e) amorphous solid layers were visible, the
208
sample was centrifuged (12 600 g, 10 min.) and the collected precipitate was washed with
209
deionized water. The dried precipitate was again analyzed by SEM with EDX. As shown in
210
Fig. 3f, the sample was composed of nanometric particles. The weight and atomic percentages
211
of europium in the sample were 35.48 wt% and 5.72 at%, respectively (see Table 3). The
212
increased concentration of europium in the analyzed sample as compared to the previous
213
results (see Table 2), confirmed that the soluble impurities were removed during
214
centrifugation, and that the sample was composed mainly of europium oxide nanoparticles.
215
The sample consisted of: Eu(OH)3 as a substrate (taking no part in the conversion process),
216
Eu2O3 as a product of this process, and M13 phages. However, Eu oxide, which is insoluble in
217
water but is able to absorb water, could form an additional amount of Eu(OH)336.
218
219
220
11 ACS Paragon Plus Environment
Bioconjugate Chemistry
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 12 of 26
221
Table 3. Elemental composition of centrifuged nanoparticles synthesized by M13 PG-Eu-3,
222
analyzed in Fig. 3f.
223
224
Element
OK
Na K
Cl K
Eu L
Weight [%]
23.51
5.84
16.10
54.55
Atomic [%]
57.16
10.37
18.8
14.39
225
226
Additionally, the synthesis of Eu2O3 nanoparticles in the presence of chemically
227
synthesized SRTGNWTRIDQS peptide only was performed. Scanning electron microscopy
228
and transmission electron microscopy were used to study the morphology of the samples. The
229
results are depicted in Fig. 4 and 5.
230
a
b
231 232
Figure 4. SEM images of control sample (a) and Eu2O3 nanoparticles obtained in peptide-
233
assisted synthesis (b). Scale bar represents 1 µm.
234
235
236
12 ACS Paragon Plus Environment
Page 13 of 26
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Bioconjugate Chemistry
a
b
237 238
Figure 5. TEM images of control sample (a) and Eu2O3 nanoparticles obtained in peptide-
239
assisted synthesis (b). Scale bars represent 100 nm. Inset shows a single nanoparticle, with a
240
peptide shell, obtained in peptide-assisted synthesis. Scale bar represents 25 nm.
241
242
Figures 4a and 5a, indicate that in the case of the control sample an amorphous material was
243
obtained. In contrast, the peptide-assisted synthesis led to the formation of 25-30 nm Eu2O3
244
nanocrystals. In inset in Fig. 5b a single nanoparticle is shown, with a shell probably
245
composed of peptides.
246
X-ray powder diffraction spectroscopy (XRD) was used to verify the crystallinity of
247
the samples. The XRD pattern for nanoparticles synthesized in the presence of the selected
248
peptide is shown in Fig. 6B. Reflexes can be seen at 28.3°, 32.8°, 47.1° and 55.8°, and they
249
were indexed to (2 2 2), (4 0 0), (4 4 0) and (6 2 2), respectively. It indicates that body-
250
centered cubic Eu2O3 crystals were produced (JCPDS No. 34-0392). Particle size estimated
251
from the diffraction spectrum by using half-maximum widths was in the range of 26−30 nm,
252
which is in agreement with estimations based on SEM and TEM images. The XRD spectrum
13 ACS Paragon Plus Environment
Bioconjugate Chemistry
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 14 of 26
253
of the control sample revealed its amorphous character, with broad bumps instead of well-
254
defined reflexes. Similar results were published by others 19, 37, 38.
255
256 257
Figure 6. XRD pattern of control sample (A) and Eu2O3 nanoparticles obtained in peptide-
258
assisted synthesis (B).
259
260
Luminescence spectra
261
Excitation and emission spectra of the Eu2O3 nanoparticles synthesized by M13 PG-
262
Eu-3 are displayed in Fig. 7a and 7b, respectively. The excitation spectrum (a) consists of four
263
distinct, sharp bands at 375, 394, 452 and 561 nm, corresponding to electronic transitions of
264
Eu3+ from 7F0 to 5L1, 5L6, 5D3 and 5D0, respectively. There is also a weak band at 465 nm
265
ascribed to 7F0 → 5D2 transition39. The emission spectrum (b) contains emission bands peaked
266
at 432, 467 and 536 nm, which are attributed to 5D3 → 7F2, 5D2 → 7F0 and 5D1 → 7F2,
267
respectively. The following bands are present above 550 nm: a very weak band related to 5D0
268
→ 7F0 at 579 nm and then more distinct bands at 593 (5D0 → 7F1), 615 (5D0 → 7F2), 646 (5D0
269
→ 7F3) and 698 nm (5D0 → 7F4). 14 ACS Paragon Plus Environment
Page 15 of 26
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Bioconjugate Chemistry
270 271
Figure 7. Excitation and emission spectra. Excitation spectrum of Eu2O3 synthesized in the
272
presence of M13 PG-Eu-3 (λem = 595 nm) (panel a), and emission spectrum of M13 PG-Eu-
273
3/Eu2O3 nanoparticles (λexc = 395 nm) (panel b).
274
275
Since Eu3+ ion can serve as a symmetry indicator of its nearest environment, the point
276
of interest is the intensity ratio of the lines at 593 and 615 nm. If in the emission spectrum the
277
5
278
possesses inversion symmetry. In the opposite case (no inversion symmetry), the line
279
domination is vice versa39. As observed in Fig. 7b, the intensity of the 5D0 → 7F2 band
280
distinctly dominates over the 5D0 → 7F1 one. Thus, concentration of the Eu3+ sites deviated
281
from the inversion symmetry was much higher than concentration of the Eu3+ occupied sites
282
of this symmetry. This effect indicates that the majority of the Eu3+ ions existed in Eu2O3 and
283
- especially in Eu(OH)3 - in sites of lower symmetry.
284
D0 → 7F1 line dominates over the 5D0 → 7F2 one, it means that the site of the europium ions
In conclusion, this study has for the first time reported peptides specifically binding
285
Eu2O3 nanoparticles. Moreover, we have for the first time demonstrated that bacteriophages
286
exposing selected peptides can efficiently synthesize Eu2O3 nanoparticles. The synthesis was
287
dependent solely on the presence of 1) the phage and 2) Eu(III) precursors. It should be noted
288
that -in contrast to other known methods for Eu2O3 NPs synthesis - no thermal treatment of
15 ACS Paragon Plus Environment
Bioconjugate Chemistry
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 16 of 26
289
samples was required. As a result of phage-assisted synthesis, uniform Eu2O3 quantum dots
290
were obtained. The light emission of the Eu2O3 NPs obtained was demonstrated. While we
291
observed Eu3+ emission, in our experimental procedure it was not very high, which could be
292
explained by two different phenomena. Firstly, in Eu(OH)3 and Eu2O3 formed in aqueous
293
surrounding, Eu3+ ions coordinated with H2O ligands possessing O-H oscillators that
294
effectively quench emission of the central ion, were present40. Secondly, since concentration
295
of Eu was as high as 54 wt%, the concentration quenching effect was observed.
296
297
EXPERIMENTAL PROCEDURES
298
Materials
299
Phage clones isolated from Ph.D.™-12 Phage Display Peptide Library (New England
300
Biolabs, NEB) and the control phage M13KE with the wild-type pIII protein (NEB) were
301
used. Escherichia coli ER2738 (NEB) was used in all experiments. Materials were from
302
Sigma-Aldrich unless otherwise noted.
303
304
Bacteriophage propagation, concentration and purification
305
Propagation of phages was carried out in E. coli ER2738 in Luria-Bertani (LB) medium.
306
Bacteriophages were added to the bacterial culture in an early exponential growth phase and
307
propagated for 5 h at 37°C with vigorous shaking. Next, bacteriophages were concentrated
308
and purified with the use of polyethylene glycol 8000 according to the M13 Amplification
309
protocol (NEB). Then, depending on the type of further analyses, phages were suspended in
310
distilled water or TBS buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl). Titration of phages
311
was carried out on double-agar plates containing Xgal/IPTG26. 16 ACS Paragon Plus Environment
Page 17 of 26
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Bioconjugate Chemistry
312
Biopanning procedures
313
For isolation and identification of peptide sequences that specifically bind Eu2O3, a triple
314
biopanning procedure was used. Ten milligrams of 99.999% Eu2O3 trace metals basis was
315
incubated in TBST buffer (TBS and 0.1 % Tween-20) for 1 h at RT and next washed six times
316
with TBST buffer. Ten microliters of Phage Display Peptide Library was added to Eu2O3 in 1
317
ml TBST, incubated for 30 min at RT and next washed ten times with TBST. After the
318
washing procedure, Eu2O3-bound phages were eluted with a buffer containing 0.2 M Glycine-
319
HCl pH 2.2 and 1 mg/ml BSA and incubated with shaking for 10 min at RT. The eluted
320
phages were then centrifuged (5 min, 4000 g, RT). The supernatant containing the eluted
321
phages was immediately used in propagation and/or titration procedures. After the third
322
biopanning procedure, eluted phages were titrated on double-agar plates containing
323
Xgal/IPTG. Phages from single plaques were used in propagation procedures, as described
324
above. SsDNA was isolated from the propagated phages (according to a method described by
325
Wilson41) and sequenced with the use of 96 gIII sequencing primer (NEB).
326
327
Analysis of efficiency of Eu2O3 binding
328
Efficiency assay was developed on the basis of a previous report33. Specific concentration of
329
phages (108 - 109 plaque forming unit (pfu)/ml) propagated after three rounds of biopanning
330
procedure, was added to 10 mg Eu2O3 (prepared as described in a biopanning procedure
331
above). These phages are designated in this work as input phages (I). Eluted phages (obtained
332
in the procedure described above) were titrated on double-agar plates containing Xgal/IPTG
333
and designated as output phages (O). Binding efficiency was expressed as the ratio of the
334
output/input (O/I) phages. As a control, we employed M13KE phage with the wild-type pIII
335
protein. 17 ACS Paragon Plus Environment
Bioconjugate Chemistry
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 18 of 26
336
Atomic force microscopic (AFM) analysis
337
Atomic force microscopic (AFM) images were obtained with a MultiMode AFM instrument
338
using a Nanoscope V controller (Bruker) operating in the tapping mode using an uncoated
339
RFESP tip (Bruker). Cantilever’s spring constant was 3 N/m. The scanning area was 5×5 µm.
340
Raw AFM data were processed with Gwyddion 2.32 SPM data analysis and visualization tool.
341
First, mica was cleaved in order to obtain a clean surface. Next, 10 mg of Eu2O3 was
342
dispersed in 0.5 ml of water by sonication. Ten microliters of the resulting Eu2O3 dispersion
343
was deposited on mica. The sample was left under ambient conditions to let the water
344
evaporate. A five-microliter droplet of M13 PG-Eu-3 or M13KE suspensions (with a
345
concentration of 1010 - 1011 pfu/ml) in TBS buffer was deposited on Eu2O3-modified mica and
346
left under cover at RT for 30 minutes to let the phages interact with Eu2O3 particles. The
347
cover was essential to prevent water evaporation. After incubation, the sample was rinsed
348
with water to remove the non-specifically bound phages and buffer residues, and dried in a
349
stream of argon. After drying, the sample was ready for imaging.
350
351
Nanoparticle synthesis
352
For Eu2O3 NP synthesis, we used both the phages presenting peptides on pIII protein and the
353
selected peptides only. In the synthesis with the use of phages, 4 µl of 10-3 M europium nitrate
354
solution was added to 30 ml of M13 PG-Eu-3 and M13KE phage suspensions (1011 pfu/ml).
355
The reaction mixtures were left overnight; after that time, the samples were subjected to
356
analyses. Simultaneously, 40 µl of 5·10-4 M Eu(OH)3 solution was added to 30 ml of M13
357
PG-Eu-3 and 30 ml of M13KE phage suspensions, and left overnight. The 5·10-4 M Eu(OH)3
358
solution was prepared by mixing the same volumes of 10-3 M Eu(NO3)3 solution and 3·10-3 M
359
NaOH solution. In the synthesis with the use of the selected peptide only, 20 mg of peptide
18 ACS Paragon Plus Environment
Page 19 of 26
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Bioconjugate Chemistry
360
(synthesized chemically by a commercial service) was added to the mixture of Eu(NO3)3 (5
361
mL, 0.2 mM) and NaOH (5 mL, 1.6 mM) under magnetic stirring. In the control experiment,
362
the same amounts of Eu(NO3)3 and NaOH solutions were mixed, but with no peptide added.
363
The mixtures were stirred overnight at RT. After that time, the precipitates were collected by
364
centrifugation, and washed several times with deionized water. The precipitate was dried
365
overnight in a vacuum dryer (40°C, 0.01 bar).
366 367
Transmission electron microscopy analysis
368
For TEM analysis, Eu2O3 NPs synthesized by the selected SRTGNWTRIDQS peptide were
369
placed on grids coated with a 2% collodion solution and carbon. Eu2O3 NPs were negatively
370
stained with 2% uranyl acetate or were examined without staining using Philips CM100
371
electron microscope at 80kV.
372 373
Scanning electron microscope (SEM) analysis
374
For SEM analysis (FEI Quanta FEG 250), aqueous solutions of the samples were dropped
375
onto a carbon conducting support and left overnight to dry at RT. If necessary, samples were
376
covered with thin films of gold, using a high vacuum sputter coater (Leica EM SCD 500).
377 378
X-ray Diffraction analysis
379
X-ray diffraction patterns (XRD) were recorded on a X-ray diffractometer (Xpert PRO MPD,
380
Philips) with Cu target Kα-ray (λ=0.15404 nm) irradiation. Scans were taken in the 2θ range
381
of 10-80°.
382
19 ACS Paragon Plus Environment
Bioconjugate Chemistry
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 20 of 26
383
Energy-dispersive X-ray (EDX) spectroscopy
384
For chemical characterization of the samples, EDX spectroscopy was performed using the
385
EDAX Genesis APEX 2i with Apollo X SDD spectrometer at 10 kV.
386
387
Luminescence spectroscopy
388
Front-face emission and excitation spectra were measured at RT using a HORIBA Jobin Yvon
389
Fluoromax-4 spectrofluorometer with a reflection spectra attachment. None of the excitation
390
spectra was corrected for the lamp and photomultiplier response.
391
392
ACKNOWLEDGEMENTS
393
We would like to thank Dr. Magdalena Narajczyk for her help with TEM. This work was
394
supported by National Science Center (Poland) within the project grant no. N N302 181439
395
(to G.W.).
396
397
CONFLICT OF INTEREST
398
There are no conflicts of interest to declare.
399
400
REFERENCES
401
(1) Sayyadi, N., Justiniano, I., Connally, R. E., Zhang, R., Shi, B. Y., Kautto, L., Everest-
402
Dass, A. V., Yuan, J. L., Walsh, B. J., Jin, D. Y., et al. (2016) Sensitive Time-Gated
20 ACS Paragon Plus Environment
Page 21 of 26
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Bioconjugate Chemistry
403
Immunoluminescence Detection of Prostate Cancer Cells Using a TEGylated Europium
404
Ligand. Anal Chem 88, 9564-9571.
405
(2) Skaudzius, R., Enseling, D., Skapas, M., Selskis, A., Pomjakushina, E., Justel, T., Kareiva,
406
A., and Ruegg, C. (2016) Europium-enabled luminescent single crystal and bulk YAG and
407
YGG for optical imaging. Opt Mater 60, 467-473.
408
(3) Wu, T., Kessler, J., and Bour, P. (2016) Chiral sensing of amino acids and proteins
409
chelating with Eu-III complexes by Raman optical activity spectroscopy. Phys Chem Chem
410
Phys 18, 23803-23811.
411
(4) Sy, M., Nonat, A., Hildebrandt, N., and Charbonniere, L. J. (2016) Lanthanide-based
412
luminescence biolabelling. Chem Commun 52, 5080-5095.
413
(5) Choi, Y. I., Yoon, Y., Kang, J. G., and Sohn, Y. (2015) Photoluminescence imaging of
414
Eu(III) and Tb(III)-embedded SiO2 nanostructures. J Lumin 158, 27-31.
415
(6) Bazzi, R., Flores, M. A., Louis, C., Lebbou, K., Zhang, W., Dujardin, C., Roux, S.,
416
Mercier, B., Ledoux, G., Bernstein, E., et al. (2004) Synthesis and properties of europium-
417
based phosphors on the manometer scale: Eu2O3, Gd2O3 : Eu, and Y2O3 : Eu. J Colloid
418
Interf Sci 273, 191-197.
419
(7) Wu, G. S., Zhang, L. D., Cheng, B. C., Xie, T., and Yuan, X. Y. (2004) Synthesis of
420
Eu2O3 nanotube arrays through a facile sol-gel template approach. J Am Chem Soc 126,
421
5976-5977.
422
(8) Eilers, H., and Tissue, B. M. (1996) Laser spectroscopy of nanocrystalline Eu2O3 and
423
Eu3+:Y2O3. Chem Phys Lett 251, 74-78.
424
(9) Bihari, B., Eilers, H., and Tissue, B. M. (1997) Spectra and dynamics of monoclinic
425
Eu2O3 and Eu3+:Y2O3 nanocrystals. J Lumin 75, 1-10.
426
(10) Wakefield, G., Keron, H. A., Dobson, P. J., and Hutchison, J. L. (1999) Synthesis and
427
properties of sub-50-nm europium oxide nanoparticles. J Colloid Interf Sci 215, 179-182.
21 ACS Paragon Plus Environment
Bioconjugate Chemistry
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 22 of 26
428
(11) Pol, V. G., Reisfeld, R., and Gedanken, A. (2002) Sonochemical synthesis and optical
429
properties of europium oxide nanolayer coated on titania. Chem Mater 14, 3920-3924.
430
(12) Si, R., Zhang, Y. W., You, L. P., and Yan, C. H. (2005) Rare-earth oxide nanopolyhedra,
431
nanoplates, and nanodisks. Angew Chem Int Edit 44, 3256-3260.
432
(13) Pol, V. G., Palchik, O., Gedanken, A., and Felner, I. (2002) Synthesis of europium oxide
433
nanorods by ultrasound irradiation. J Phys Chem B 106, 9737-9743.
434
(14) Wang, X., and Li, Y. D. (2003) Rare-earth-compound nanowires, nanotubes, and
435
fullerene-like nanoparticles: Synthesis, characterization, and properties. Chem-Eur J 9, 5627-
436
5635.
437
(15) Wang, X., Sun, X. M., Yu, D. P., Zou, B. S., and Li, Y. D. (2003) Rare earth compound
438
nanotubes. Adv Mater 15, 1442-1445.
439
(16) Yan, T. T., Zhang, D. S., Shi, L. Y., and Li, H. R. (2009) Facile synthesis,
440
characterization, formation mechanism and photoluminescence property of Eu2O3 nanorods.
441
J Alloy Compd 487, 483-488.
442
(17) Zhang, L. X., Jiu, H. F., Luo, J., and Chen, Q. W. (2007) High-yield synthesis of single-
443
crystal short Eu2O3 nanorods through a facile sol-gel template approach. J Cryst Growth 309,
444
192-196.
445
(18) Wang, S. F., Gu, F., Li, C. Z., and Lu, M. K. (2007) Synthesis of mesoporous Eu2O3
446
microspindles. Cryst Growth Des 7, 2670-2674.
447
(19) Zhang, D. S., Yan, T. T., Shi, L. Y., Li, H. R., and Chiang, J. F. (2010) Template-free
448
synthesis, characterization, growth mechanism and photoluminescence property of Eu(OH)(3)
449
and Eu2O3 nanospindles. J Alloy Compd 506, 446-455.
450
(20) Li, Y., Ge, M., Li, J. W., Wang, J. F., and Zhang, H. J. (2011) Synthesis of mesoporous
451
Eu2O3 microspheres and Eu2O3 nanoparticle-wires as well as their optical properties.
452
Crystengcomm 13, 637-641.
22 ACS Paragon Plus Environment
Page 23 of 26
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Bioconjugate Chemistry
453
(21) Viana, R. D., Falcao, E. H. L., Dutra, J. D. L., da Costa, N. B., Freire, R. O., and Alves,
454
S. (2014) New experimental and theoretical approach in Eu2O3 microspheres: From synthesis
455
to a study of the energy transfer. J Photoch Photobio A 281, 1-7.
456
(22) Smith, G. P. (1985) Filamentous Fusion Phage - Novel Expression Vectors That Display
457
Cloned Antigens on the Virion Surface. Science 228, 1315-1317.
458
(23) Pande, J., Szewczyk, M. M., and Grover, A. K. (2010) Phage display: Concept,
459
innovations, applications and future. Biotechnol Adv 28, 849-858.
460
(24) Sidhu, S. S., Lowman, H. B., Cunningham, B. C., and Wells, J. A. (2000) Phage display
461
for selection of novel binding peptides. Applications of Chimeric Genes and Hybrid Proteins,
462
Pt C 328, 333-363.
463
(25) Wolcke, J., and Weinhold, E. (2001) A DNA-binding peptide from a phage display
464
library. Nucleos Nucleot Nucl 20, 1239-1241.
465
(26) Golec, P., Karczewska-Golec, J., Los, M., and Wegrzyn, G. (2012) Novel ZnO-binding
466
peptides obtained by the screening of a phage display peptide library. J Nanopart Res 14.
467
(27) Vetter, S. W. (2013) Phage display selection of peptides that target calcium-binding
468
proteins. Methods Mol. Biol. 963, 215-35.
469
(28) Dickerson, M. B., Sandhage, K. H., and Naik, R. R. (2008) Protein- and Peptide-Directed
470
Syntheses of Inorganic Materials. Chem Rev 108, 4935-4978.
471
(29) Pavlidou, M., Hanel, K., Mockel, L., and Willbold, D. (2013) Nanodiscs Allow Phage
472
Display Selection for Ligands to Non-Linear Epitopes on Membrane Proteins. Plos One 8.
473
(30) Dharmasena, M. N., Jewell, D. A., and Taylor, R. K. (2007) Development of peptide
474
mimics of a protective epitope of Vibrio cholerae ogawa o-antigen and investigation of the
475
structural basis of peptide mimicry. J Biol Chem 282, 33805-33816.
476
(31) Seker, U. O. S., and Demir, H. V. (2011) Material Binding Peptides for Nanotechnology.
477
Molecules 16, 1426-1451.
23 ACS Paragon Plus Environment
Bioconjugate Chemistry
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 24 of 26
478
(32) Sugimura, Y., Hosono, M., Wada, F., Yoshimura, T., Maki, M., and Hitomi, K. (2006)
479
Screening for the preferred substrate sequence of transglutaminase using a phage-displayed
480
peptide library - Identification of peptide substrates for TGase 2 and Factor XIIIA. J Biol
481
Chem 281, 17699-17706.
482
(33) Sano, K. I., and Shiba, K. (2003) A hexapeptide motif that electrostatically binds to the
483
surface of titanium. J Am Chem Soc 125, 14234-14235.
484
(34) Feng, J., Shan, G. M., Maquieira, A., Koivunen, M. E., Guo, B., Hammock, B. D., and
485
Kennedy, I. M. (2003) Functionalized europium oxide nanoparticles used as a fluorescent
486
label in an immunoassay for atrazine. Anal Chem 75, 5282-5286.
487
(35) Huhtinen, P., Kivela, M., Kuronen, O., Hagren, V., Takalo, H., Tenhu, H., Lovgren, T.,
488
and Harma, H. (2005) Synthesis, characterization, and application of Eu(III), Tb(III), Sm(III),
489
and Dy(III) lanthanide chelate nanoparticle labels. Anal Chem 77, 2643-2648.
490
(36) Greenwood, N. N., and Earnshaw, A. (1997) in Chemistry of the Elements pp 1227-1249,
491
Elsevier, Oxford.
492
(37) Kang, J. G., Jung, Y., Min, B. K., and Sohn, Y. (2014) Full characterization of Eu(OH)3
493
and Eu2O3 nanorods. Appl Surf Sci 314, 158-165.
494
(38) Kattel, K., Park, J. Y., Xu, W. L., Kim, H. G., Lee, E. J., and Bony, B. A. (2012) Water-
495
soluble ultrasmall Eu2O3 nanoparticles as a fluorescent imaging agent: In vitro and in vivo
496
studies. Colloids Surf A Physicochem Eng Asp 394, 85-91.
497
(39) Blasse, G., and Grabmaier, B. C. (1994) in Luminescent Materials pp 112-130, Springer-
498
Verlag, Berlin.
499
(40) Horrocks, W. D., and Sudnick, D. R. (1979) Lanthanide Ion Probes of Structure in
500
Biology - Laser-Induced Luminescence Decay Constants Provide a Direct Measure of the
501
Number of Metal-Coordinated Water-Molecules. J Am Chem Soc 101, 334-340.
24 ACS Paragon Plus Environment
Page 25 of 26
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Bioconjugate Chemistry
502
(41) Wilson, R. K. (1993) High-Throughput Purification of M13 Templates for DNA-
503
Sequencing. Biotechniques 15, 414-&.
504 505 506 507 508 509
510
511
512
513
514
515
516
517
518
519
520
521
522
25 ACS Paragon Plus Environment
Bioconjugate Chemistry
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 26 of 26
523
524
525
TOC
526
Binding to Eu2O3 NPs
Binding to Eu2O3 NPs
Synthesis of Eu2O3 NPs
Synthesis of Eu2O3 NPs
26 ACS Paragon Plus Environment